ABUS

ABUS Biotechnology MRNA Petri Dish Reports ROIV Uncategorized

Why Moderna’s $950M Patent Bill Is A Small Price For Pipeline Freedom

Mar 4, 2026

ABUS Biotechnology MRNA ROIV Uncategorized

Moderna gains as Arbutus/ Genevant settlement removes major financial risk

Mar 4, 2026

ABUS Biotechnology MRNA ROIV Uncategorized

Moderna surges after hours on patent settlement with Arbutus and Genevant

Mar 3, 2026

ABUS Biotechnology MRNA Uncategorized

Moderna dealt blows in ongoing patent dispute with Arbutus

Feb 18, 2026

ABUS Biotechnology MRNA ROIV Uncategorized

Arbutus jumps on ruling in patent dispute with Moderna

Feb 2, 2026

arbutus-falls-as-patent-dispute-with-moderna-hits-eu-snag

ABUS Biotechnology MRK MRNA Uncategorized

Arbutus falls as patent dispute with Moderna hits EU snag

Jan 16, 2026

Comments (3) stocknshares Arbutus Biopharma (ABUS) lost ~14% in the premarket on Friday after the...